Characterization of the kynurenine pathway in human neurons

被引:242
作者
Guillemin, Gilles J.
Cullen, Karen M.
Lim, Chai K.
Smythe, George A.
Garner, Brett
Kapoor, Vimal
Takikawa, Osamu
Brew, Bruce J.
机构
[1] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2052, Australia
[2] Univ New S Wales, Biomed Mass Spectrometry Facil, Sydney, NSW 2052, Australia
[3] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia
[4] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia
[5] St Vincents Hosp, Ctr Immunol, Sydney, NSW 2010, Australia
[6] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia
[7] St Vincents Hosp, Dept HIV Med, Sydney, NSW 2010, Australia
[8] Prince Wales Med Res Inst, Randwick, NSW 2031, Australia
[9] Univ Western Australia, Dept Med & Pharmacol, Crawley, WA 6009, Australia
[10] Natl Inst Longev Sci, Natl Ctr Geriatr & Gerontol, Lab Radiat Safety, Morioka, Obu 4748511, Japan
关键词
human neurons; neuroblastoma; kynurenine pathway; indoleamine 2,3-dioxygenase; picolinic acid; quinolinic acid; neurotoxicity; tumor tolerance;
D O I
10.1523/JNEUROSCI.4101-07.2007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The kynurenine pathway is a major route of L-tryptophan catabolism producing neuroactive metabolites implicated in neurodegeneration and immune tolerance. We characterized the kynurenine pathway in human neurons and the human SK-N-SH neuroblastoma cell line and found that the kynurenine pathway enzymes were variably expressed. Picolinic carboxylase was expressed only in primary and some adult neurons but not in SK-N-SH cells. Because of this difference, SK-N-SH cells were able to produce the excitotoxin quinolinic acid, whereas human neurons produced the neuroprotectant picolinic acid. The net result of kynurenine pathway induction in human neurons is therefore predicted to result in neuroprotection, immune regulation, and tumor inhibition, whereas in SK-N-SH cells, it may result in neurotoxicity, immune tolerance, and tumor promotion. This study represents the first comprehensive characterization of the kynurenine pathway in neurons and the first description of the involvement of the kynurenine pathway as a mechanism for controlling both tumor cell neurotoxicity and persistence.
引用
收藏
页码:12884 / 12892
页数:9
相关论文
共 65 条
[21]  
GUILLEMIN GJ, 2007, IN PRESS INT C, V1304
[22]   Glial cell line-derived neurotrophic factor (GDNF) family ligands reduce the sensitivity of neuroblastoma cells to pharmacologically induced cell death, growth arrest and differentiation [J].
Hansford, LA ;
Marshall, GA .
NEUROSCIENCE LETTERS, 2005, 389 (02) :77-82
[23]   Kynurenine metabolism in multiple sclerosis [J].
Hartai, Z ;
Klivenyi, P ;
Janaky, T ;
Penke, B ;
Dux, L ;
Vecsei, L .
ACTA NEUROLOGICA SCANDINAVICA, 2005, 112 (02) :93-96
[24]   Human microglia convert L-tryptophan into the neurotoxin quinolinic acid [J].
Heyes, MP ;
Achim, CL ;
Wiley, CA ;
Major, EO ;
Saito, K ;
Markey, SP .
BIOCHEMICAL JOURNAL, 1996, 320 :595-597
[25]  
Heyes MP, 1996, ADV EXP MED BIOL, V398, P125
[26]  
Heyes MP, 1997, J NEUROCHEM, V69, P1519
[27]   Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types [J].
Heyes, MP ;
Chen, CY ;
Major, EO ;
Saito, K .
BIOCHEMICAL JOURNAL, 1997, 326 :351-356
[28]   Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques [J].
Heyes, MP ;
Saito, K ;
Lackner, A ;
Wiley, CA ;
Achim, CL ;
Markey, SP .
FASEB JOURNAL, 1998, 12 (10) :881-896
[29]   The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression:: Physiopathological implications [J].
Hilmas, C ;
Pereira, EFR ;
Alkondon, M ;
Rassoulpour, A ;
Schwarcz, R ;
Albuquerque, EX .
JOURNAL OF NEUROSCIENCE, 2001, 21 (19) :7463-7473
[30]   QUINOLINATE-INDUCED CORTICAL CHOLINERGIC DAMAGE - MODULATION BY TRYPTOPHAN-METABOLITES [J].
JHAMANDAS, K ;
BOEGMAN, RJ ;
BENINGER, RJ ;
BIALIK, M .
BRAIN RESEARCH, 1990, 529 (1-2) :185-191